Technology | Contrast Media | November 02, 2015

4Fr and 5Fr Powerwands now ideal for virtually all CT contrast studies

Access Scientific, Powerwand midline IV catheter, CT contrast injection

Image courtesy of Access Scientific LLC


November 2, 2015 — Access Scientific LLC announced validation of the Powerwand midline IV catheter for power-injectable capability up to 8ml/sec, 325 psi for up to 10 cycles. The addition of this performance capability makes both 4Fr and 5Fr Powerwands ideal for virtually all computed tomography (CT) contrast studies, to meet the most demanding injection protocols.

The Powerwand now combines high power injectability with a low total complication rate, high flow rates and high rate for completion of therapy. Moreover, in peer-reviewed published studies and scientific posters, the Powerwand has consistently exhibited kink-resistance and blood drawability, making one-stick hospitalizations not only possible but also common.

The catheter combines ChronoFlex C material with Access Scientific’s proprietary kink-resistant process for enhanced performance.

For more information: www.accessscientific.com


Related Content

News | Artificial Intelligence

June 18, 2024 — The advancement of Artificial Intelligence (AI) in healthcare to support diagnostic decision making ...

Time June 18, 2024
arrow
News | Artificial Intelligence

June 5, 2024 — Nano-X Imaging, an innovative medical imaging technology company, today announced that its deep-learning ...

Time June 05, 2024
arrow
News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
News | Lung Imaging

May 24, 2024 — Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of ...

Time May 24, 2024
arrow
News | Radiology Business

May 22, 2024 — Medtronic has announced new preliminary data from the VERITAS clinical study using its ILLUMISITE ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...

Time May 15, 2024
arrow
News | Pediatric Imaging

May 15, 2024 — Transfer learning (TL) models trained on heterogeneous public datasets and fine-tuned using institutional ...

Time May 15, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Subscribe Now